Rating History for Keryx Biopharmaceuticals (KERX) by Dawson James

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/27/2012 N/A New Coverage Buy
(N/A)
4.00
(N/A)
2.89
(3.36)
16.26% Details